Psychiatry & Neurology, Neuromuscular Medicine · Washington, DC
NPI
1265852206
Since 2014
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
3800 Reservoir Rd NW Medstar Georgetown University Hosp, Phc Building 7th Floor
Washington, DC, 20007
Phone (202) 444-1774
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
413 services
Medicare patients, 2024
194
Average age 71
Drug cost, 2024
$6.7M
1,286 prescriptions
Company payments, 2025
$297
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara Dehbashi was code 99215 (office e&m - established), 38 times for 30 patients. In total Sara Dehbashi billed 413 services in 25 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 38 | 30 | $113.54 | $4,314 |
| 95885 Electrical Nerve Conductivity | Facility | 36 | 34 | $13.34 | $480 |
| 95913 Electrical Nerve Conductivity | Facility | 35 | 35 | $147.05 | $5,147 |
| 95886 Electrical Nerve Conductivity | Facility | 32 | 32 | $35.65 | $1,141 |
| 99222 Hospital E&M - Initial | Facility | 29 | 28 | $101.65 | $2,948 |
| 99215 Office E&M - Established | Office | 28 | 23 | $121.82 | $3,411 |
| 99214 Office E&M - Established | Facility | 25 | 22 | $71.94 | $1,799 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 23 | 19 | $13.28 | $305 |
| 99205 Office E&M - New | Facility | 20 | 20 | $131.89 | $2,638 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 13 | $63.48 | $1,270 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 17 | 17 | $13.22 | $225 |
| 95912 Electrical Nerve Conductivity | Facility | 17 | 17 | $102.66 | $1,745 |
| 99214 Office E&M - Established | Office | 17 | 16 | $76.18 | $1,295 |
| 99233 Hospital E&M - Subsequent | Facility | 16 | 12 | $95.50 | $1,528 |
| 99205 Office E&M - New | Office | 13 | 13 | $146.07 | $1,899 |
By year: 2022 $41K for 468 services; 2023 $37K for 409 services; 2024 $34K for 413 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sara Dehbashi prescribed most often to Medicare patients was Gabapentin, with 156 prescriptions and refills. In total Sara Dehbashi wrote 1,286 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 156 | 314 | 54 | $2,279 |
| Duloxetine Hcl Generic | 137 | 295 | 41 | $3,102 |
| Amitriptyline Hcl Generic | 122 | 176 | 36 | $926 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 95 | 98 | Under 11 | $1.2M |
| Pregabalin Generic | 87 | 149 | 26 | $2,699 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 82 | 88 | Under 11 | $1.6M |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 65 | 69 | Under 11 | $1.3M |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 59 | 64 | Under 11 | $772K |
| Sodium Chloride 0.9 % Sodium Chloride | 59 | 61 | Under 11 | $442 |
| Prednisone Generic | 49 | 63 | Under 11 | $207 |
| Mycophenolate Mofetil Generic | 46 | 96 | Under 11 | $13K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 37 | 41 | Under 11 | $516K |
| Pyridostigmine Bromide Generic | 25 | 73 | Under 11 | $3,224 |
| Methylprednisolone Sodium Succ Methylprednisolone Sod Succ | 21 | 21 | Under 11 | $418 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 21 | 23 | Under 11 | $394K |
Brand drugs: 486 claims; generic drugs: 800 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sara Dehbashi $297 ($297 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genentech, Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.